Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Cosmos Holdings (NASDAQ:COSM) stock increased by 117.0% to $2.3 during Wednesday's pre-market session. The company's market cap stands at $40.3 million.
  • Acutus Medical (NASDAQ:AFIB) shares moved upwards by 48.47% to $1.19. The company's market cap stands at $33.6 million.
  • Nutex Health (NASDAQ:NUTX) stock moved upwards by 14.97% to $8.83. The company's market cap stands at $5.6 billion.
  • Poseida Therapeutics (NASDAQ:PSTX) stock moved upwards by 10.73% to $3.3. The company's market cap stands at $206.4 million.
  • Aytu BioPharma (NASDAQ:AYTU) stock increased by 10.12% to $0.68. The market value of their outstanding shares is at $22.6 million.
  • Aptinyx (NASDAQ:APTX) shares moved upwards by 9.74% to $1.07. The company's market cap stands at $72.4 million.

Losers

  • Molecular Partners (NASDAQ:MOLN) stock fell 37.7% to $8.65 during Wednesday's pre-market session. The market value of their outstanding shares is at $279.3 million.
  • Freeline Therapeutics (NASDAQ:FRLN) shares declined by 8.91% to $0.78. The market value of their outstanding shares is at $48.0 million.
  • Incannex Healthcare (NASDAQ:IXHL) shares fell 8.68% to $6.21. The market value of their outstanding shares is at $300.6 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares decreased by 7.87% to $0.25. The market value of their outstanding shares is at $11.7 million.
  • Geovax Labs (NASDAQ:GOVX) shares decreased by 7.21% to $1.03. The market value of their outstanding shares is at $7.3 million. As per the press release, Q1 earnings came out today.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock declined by 6.54% to $1.0. The market value of their outstanding shares is at $8.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.